Prospective evaluation of allergen-component resolved diagnostic allergy testing and its relation to clinical features of allergic disease in children

Prospective evaluation of allergen-component resolved diagnostic allergy testing and its relation to clinical features of allergic disease in children - CRD-Isala

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38409

Enrollment

1000

Registered

2014-02-04

Start date

2014-01-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic disease allergy

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - each child (0-17 years of age) referred (by general practitioner or hospital-based medical specialist) to the Isala laboratory for "allergy testing" - written informed consent from parents/caregivers

Exclusion criteria

Exclusion criteria: - no parental consent

Design outcomes

Primary

Measure	Time frame
relationship between component resolved diagnostics (specific IgE against components of major inhalant and food allergens) and symptoms of allergic disease in children (atopic dermatitis, asthma, allergic rhinitis, and food allergy)	—

Countries

Netherlands

Outcome results